Home / Biotechnology / HIV/AIDS Diagnostics Market By Product Type (Antibody Tests, Hiv-1 Antibody Confirmatory Tests, Viral Identification Testing, Hiv-2 & Group O Diagnostics Tests, Viral Load Tests, Cd4 Testing, Early Infant Diagnosticss) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

HIV/AIDS Diagnostics Market By Product Type (Antibody Tests, Hiv-1 Antibody Confirmatory Tests, Viral Identification Testing, Hiv-2 & Group O Diagnostics Tests, Viral Load Tests, Cd4 Testing, Early Infant Diagnosticss) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

Published: Jun 2017 | Report Code: 58512-06-17

According to WHO study, until now around 70 million people are infected with HIV virus and 35 million died of HIV infection. With rising mortality, the government and non-government institutes are taking initiatives and providing funding for diagnostic treatment and prevention of HIV/AIDS. With  advancement of technology, novel diagnostic product are available in market which required minimum technical skills such as portable cell counter and point of care rapid diagnostic tests that fasten the diagnosis process. In developing countries such as India and China with growing population, rising awareness about HIV and emerging economies will be lucrative market for HIV/AIDS diagnostics. Increase in incidence of HIV infection, awareness about HIV/AIDs diagnosis and treatment, rising research and development for early diagnosis, treatment and prevention are key the factors driving the HIV/AIDS diagnostic market. 

The report titled “HIV/AIDS Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall HIV/AIDS diagnostics market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of product and different geographies. The product type segment studied for analyzing the overall global HIV/AIDS diagnostics market is majorly segmented into antibody test, HIV-2 & Group O diagnostic Tests, viral load tests, CD4 testing, early infant diagnostics, viral identification testing.

Geographically, the global HIV/AIDS diagnostics market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2016-2024 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global HIV/AIDS diagnostics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global HIV/AIDS diagnostics market. This report concludes with company profiles section that highlights major information about the key players engaged in global HIV/AIDS diagnostics market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

HIV/AIDS Diagnostics Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global HIV/AIDS Diagnosticss Market Portraiture
2.2 Global HIV/AIDS Diagnosticss Market Share, by Product Type, 2016 Vs 2025 (Value %)
2.3 Global HIV/AIDS Diagnosticss Market, by Geography, 2016 (Value %)

Chapter 3 Global HIV/AIDS Diagnosticss Market Analysis
3.1 Global HIV/AIDS Diagnosticss Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in HIV/AIDS Diagnostics Market

Chapter 4 Global HIV/AIDS Diagnostics Market Analysis, by Product Type, 2015-2025 (US$ Mn)
4.1 Introduction
4.2 Antibody Tests
4.2.1 HIV-1 Screening Tests
4.2.2 ELISA
4.2.3 Rapid Tests
4.2.4 Home Access Dried Blood Spots
4.3 HIV-1 Antibody Confirmatory Tests
4.3.1 Western Blot Tests
4.3.2 Indirect Immunofluorescence Assays (IFA)
4.3.3 Line Immunoassays
4.3.4 Radio-Immunoprecipitation Assays
4.4 Viral Identification testing
4.4.1 P24 Antigen
4.4.2 Qualitative PCR Test
4.4.3 Viral Culture
4.5 HIV-2 & Group O Diagnostics Tests
4.6 Viral Load Tests
4.7 CD4 Testing
4.8 Early Infant Diagnosticss

Chapter 5 Global HIV/AIDS Diagnostics Market, By Geography, 2015-2025 (US$ Mn)
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of APAC)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Abbvie Inc.
6.3 Alere Inc.
6.4 Apogee Flow Systems
6.5 Beckman Coulter, Inc.
6.6 Becton, Dickinson & Company
6.7 BD Biosciences
6.8 Bio-Rad Laboratories
6.9 BioMerieux
6.10 Bristol-Myers Squibb
6.11 Cepheid
6.12 Chembio Diagnostics Systems
6.13 Daktari Diagnosticss
6.14 Gilead Sciences
6.15 Hologic Inc.
6.16 Merch & Co. Inc
6.17 Mylan Inc
6.18 Janssen Therapeutics

List Of Table :

TABLE 1 Global HIV/AIDS Diagnostics Market, By Product Type 2015-2025 (US$ Mn)
TABLE 2 Global Antibody Tests Market, 2015-2025 (US$ Mn)
TABLE 1 Global HIV-1 Antibody Confirmatory Tests Market 2015-2025 (US$ Mn)
TABLE 1 Global Viral Identification testing Market 2015-2025 (US$ Mn)
TABLE 2 Global HIV/AIDS Diagnostics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America HIV/AIDS Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 4 Europe HIV/AIDS Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Asia Pacific HIV/AIDS Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 7 Abbvie Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 8 Alere Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 9 Apogee Flow Systems: Company Snapshot (Business Description; Financial Performance; Product Position Portfolio; News Coverage)
TABLE 10 Beckman Coulter, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 11 Becton, Dickinson & Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 12 BD Biosciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 13 Bio-Rad Laboratories: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 14 BioMerieux: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 15 Bristol-Myers Squibb: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 16 Cepheid: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 17 Chembio Diagnostics Systems: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 18 Daktari Diagnosticss: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 Gilead Sciences: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 20 Gilead Sciences: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 21 Merch & Co. Inc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 22 Mylan Inc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 23 Janssen Therapeutics: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)

List Of Figures :

FIG. 1 Global HIV/AIDS Diagnostics Market: Research Methodology
FIG. 2 Global HIV/AIDS Diagnostics Market Share, by Product type, 2016 Vs 2025 (Value %)
FIG. 3 Global HIV/AIDS Diagnostics Market, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global HIV/AIDS Diagnostics Market, by Geography
FIG. 5 Competitive Analysis: Key Players in Global HIV/AIDS Diagnostics Market
FIG. 6 Global HIV-1 Screening Tests Market, 2015 – 2025 (US$ Mn)
FIG. 7 Global ELISA Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Rapid Tests Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Home Access Dried Blood Spots Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Western Blot Tests Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Indirect Immunofluorescence Assays (IFA) Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Line Immunoassays Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Radio-Immunoprecipitation Assays Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global P24 Antigen Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Qualitative PCR Test Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Viral Culture Market, 2015 – 2025 (US$ Mn)
FIG. 17 Global HIV-2 & Group O Diagnostics Tests Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Viral Load Tests Market, 2015 – 2025 (US$ Mn)
FIG. 19 Global CD4 Testing Market, 2015 – 2025 (US$ Mn)
FIG. 20 Global Early Infant Diagnosticss Market, 2015 – 2025 (US$ Mn)
FIG. 21 Latin America HIV/AIDS Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Middle East & Africa HIV/AIDS Diagnostics Market, 2015 – 2025 (US$ Mn)

Based on the type of products, the HIV/AIDS diagnostics market is segmented as follows:

  • Antibody Tests
    • HIV-1 Screening Tests
      • ELISA
      • Rapid Tests
      • Home Access Dried Blood Spots
    • HIV-1 Antibody Confirmatory Tests
      • Western Blot Tests
      • Indirect Immunofluorescence Assays (IFA)
      • Line Immunoassays
      • Radio-Immunoprecipitation Assays
  • Viral Identification testing
    • P24 Antigen
    • Qualitative PCR Test
    • Viral Culture
  • HIV-2 & Group O Diagnostic Tests
  • Viral Load Tests
  • CD4 Testing
  • Early Infant Diagnostics

The most widely used test for detection of the HIV infection is antibody testing. Technological advancement in screening tests, rising incidence of HIV and growing awareness about blood donation, act as the major drivers of the antibody testing market. Rapid tests and ELISA form the major markets for the HIV diagnostic tests. With advances in technology, antibody confirmatory have become extremely accurate in giving end result, for example western blot test delivers 100% accuracy result screening post antibody test. Thus owing to high accuracy rate and increase in usage, antibody tests will continue to occupy dominant position in the forecast period. Monitoring tests such as viral load test, and CD4 testing are used to evaluate virologic load and assessment of the treatment safety, are anticipated to be the fastest growing market.

HIV/AIDS Diagnostics Market

For the purpose of this study, the global HIV/AIDS diagnostics market is geographically categorized into:

  • North America (U.S. & Canada)
  • Europe (U.K., Germany & Rest of Europe)
  • Asia Pacific (China, Japan, and Rest of APAC)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (UAE, Saudi Arabia, South Africa, Rest of Middle East and Africa)

HIV/AIDS Diagnostics Market

In 2016, North America dominated the global HIV/AIDS diagnostics market followed by the Europe. In North America region, U.S. occupies the maximum share of the market due to rise in prevalence of HIV infection, growing awareness programs and health care access, national funding for HIV affected people. Canada at regional level has different programs laid for treatment of AIDS, which further drives the diagnostic market in the country. Europe is the next important market driven by factors such as convenient access to health care facilities, high healthcare spending and introduction of novel treatment opportunities. Asia Pacific is anticipated to be fastest growing in HIV/AIDS diagnostic market in the forecast period. Developing countries contribute to rising number of HIV-AIDS population, and along with increase in government initiative for HIV diagnostic and treatment facilities, rising healthcare expenditure further drives the diagnostic market for Asia pacific.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients